-
Young doctors, long work hours, and inexperience are a bad combination when you're trying to improve patient safety, according to new research that provides a clear reminder of the risks inherent in a medical residency program.
-
In a tragic demonstration that increased vigilance is sometimes not enough to prevent medication errors, the same hospital that promised sweeping changes after the accidental deaths of three premature newborns reports that another error has led to the paralysis of a teenage mother.
-
A woman suffering from severe discomfort in her mouth and throat area presented to the emergency department (ED) for treatment. Over the next two days, doctors passed the patient around as they refused to respond to their on-call duties.
-
Mayo Clinics researchers say smokers admitted to intensive care units appear to be at higher risk of cardiovascular events and death if they are given nicotine replacement therapy to ameliorate acute nicotine withdrawal. The researchers presented their findings at the annual meeting of the American College of Chest Physicians.
-
Pharmacists using new technology, new knowledge, and evidence-based medicine approaches can and should play a critical role in answering questions about the value of critical pathways, according to members of the 2005 American College of Clinical Pharmacy (ACCP) Task Force on Critical Pathways.
-
FDA recently approved these drugs:
Pantheon's Zolinza (vorinostat) capsules were approved for treating cutaneous T-cell lymphoma (CTCL), a type of skin cancer, to be used when the disease persists, gets worse, or comes back during or after treatment with other medicines.
-
Iplex® (mecasermin rinfabate) and Increlex® (mecasermine) are two recently approved agents for the treatment of short stature in pediatric patients. Mecasermin rinfabate is composed of human insulin-like growth factor-1 (IGF-1) and human insulin-like growth factor-binding protein-3 (IGFBP-3).
-
Medications taken incorrectly in the United States represent annual costs of more than $100 billion.
-
Faced with the realization in the early years of this decade that 26 community pharmacies had recently closed and 12 more were at risk of closing, the North Dakota Board of Pharmacy started looking for a solution.
-
It's a daunting task to read from A to Z through the numerous clinical trials in cardiology in pursuit of a cure for acute coronary syndrome (ACS.
